SCHEMBL7708935

SCHEMBL7708935

O=C(O)c1cccc(/N=N/c2ccc(-c3ccc(/N=N/c4cccc(C(=O)O)c4)cc3)cc2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.60
RAB9A P51151 5/20 0.60
NPC1 O15118 4/20 0.60
KMT2A Q03164 4/20 0.60
MEN1 O00255 3/20 0.60
THRB P10828 2/20 0.60
ALDH1A1 P00352 2/20 0.60
POLB P06746 2/20 0.60
L3MBTL1 Q9Y468 2/20 0.60
GAA P10253 1/20 0.60
PLCG1 P19174 1/20 0.60
TRPA1 O75762 1/20 0.60
RECQL P46063 2/20 0.54
TDP1 Q9NUW8 2/20 0.54
APP P05067 1/20 0.54
BLM P54132 1/20 0.54
SMN1; SMN2 Q16637 4/20 0.54
KMO O15229 1/20 0.53
GLA P06280 1/20 0.52
CCNE2 O96020 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7708937 1.00 MAPT (0.60) MAPTRAB9ANPC1KMT2AMEN1
SCHEMBL5486185 0.90 TRPA1 (0.67) MAPTRAB9ANPC1KMT2AMEN1
SCHEMBL14437429 0.90 TRPA1 (0.67) MAPTRAB9ANPC1KMT2AMEN1
SCHEMBL69866 0.90 RAB9A (0.65) MAPTRAB9ANPC1KMT2AMEN1
SCHEMBL31045928 0.90 RAB9A (0.65) MAPTRAB9ANPC1KMT2AMEN1
SCHEMBL69865 0.90 RAB9A (0.65) MAPTRAB9ANPC1KMT2AMEN1
SCHEMBL16678896 0.87 MAPT (0.63) MAPTRAB9ANPC1KMT2AMEN1
SCHEMBL15129042 0.87 MAPT (0.63) MAPTRAB9ANPC1KMT2AMEN1
SCHEMBL11577315 0.86 MAPT (0.57) MAPTRAB9ANPC1KMT2AMEN1
SCHEMBL28422801 0.86 MAPT (0.57) MAPTRAB9ANPC1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6417178-B1 Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits UNIVERSITY OF PITTSBURGH 2002-07-09 US disclosed
EP-1110945-A2 Azocompounds for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition UNIVERSITY OF PITTSBURGH (US) 2001-06-27 EP disclosed
WO-1996034853-A1 AZOCOMPOUNDS FOR THE ANTEMORTEM DIAGNOSIS OF ALZHEIMER'S DISEASE AND IN VIVO IMAGING AND PREVENTION OF AMYLOID DEPOSITION UNIVERSITY OF PITTSBURGH (US) 1996-11-07 WO disclosed